Abeona Therapeutics Inc. (ABEO)

Abeona Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	82.88	23.36	14.47	14.22	32.94	12.6
Short-Term Investments	124.23	74.36	37.75	37.93	12.09	82.44
Cash & Short-Term Investments	207.12	97.72	52.23	52.15	45.02	95.03
Cash Growth	88.80%	87.11%	0.15%	15.82%	-52.62%	-26.48%
Accounts Receivable	-	-	-	-	3	-
Other Receivables	1.49	1.65	2.44	0.19	-	-
Total Trade Receivables	1.49	1.65	2.44	0.19	3	-
Inventory	4.85	-	-	-	-	-
Other Current Assets	2.55	1.48	1.07	0.76	8.27	2.71
Total Current Assets	216.13	100.85	55.74	53.1	56.29	97.74
Net Property, Plant & Equipment	14.42	7.98	7.99	11.07	21.74	18.35
Other Intangible Assets	-	-	-	-	1.38	1.5
Goodwill	-	-	-	-	-	32.47
Other Long-Term Assets	0.54	0.1	0.28	0.04	0.17	1.14
Total Assets	231.1	108.93	64	64.21	79.59	151.2
Accounts Payable	5.93	3.44	1.86	1.81	4.33	4.7
Accrued Expenses	7.23	6.33	5.99	3.99	5.59	3.41
Current Portion of Long-Term Debt	8.83	5.94	-	-	-	0.33
Current Portion of Leases	0.1	0.82	1	1.77	1.82	1.71
Unearned Revenue	-	-	-	-	-	0.3
Other Current Liabilities	0.04	0.06	4.58	0.2	4.9	31.52
Total Current Liabilities	22.18	16.57	13.42	7.78	16.62	41.96
Long-Term Debt	10.86	13.04	-	-	-	1.43
Long-Term Leases	4.25	2.86	4.4	5.85	7.56	5.26
Other Long-Term Liabilities	22.57	32.01	31.35	23.82	13.04	-
Total Long-Term Liabilities	37.68	47.91	35.75	29.67	20.6	6.69
Total Liabilities	59.86	64.9	49.18	37.45	37.22	48.65
Common Stock	0.52	0.46	0.27	0.18	1.47	0.96
Additional Paid-in Capital	892.31	856.82	764.15	722.05	696.56	672.3
Accumulated Other Comprehensive Income	0.01	0.01	-0.07	-0.13	-0.03	-0.01
Retained Earnings	-721.62	-813.26	-749.52	-695.34	-655.64	-570.7
Shareholders' Equity	171.23	44.03	14.83	26.76	42.37	102.55
Total Liabilities & Equity	231.1	108.93	64	64.21	79.59	151.2
Total Debt	24.05	22.66	5.4	7.63	9.38	8.73
Net Cash (Debt)	183.07	75.06	46.83	44.52	35.65	86.3
Net Cash Growth	143.91%	60.29%	5.17%	24.90%	-58.70%	-28.86%
Net Cash Per Share	3.34	1.83	2.19	5.66	9.05	23.28
Book Value	171.23	44.03	14.83	26.76	42.37	102.55
Book Value Per Share	3.12	1.07	0.69	3.40	10.76	27.67
Tangible Book Value	171.23	44.03	14.83	26.76	40.98	68.59
Tangible Book Value Per Share	3.12	1.07	0.69	3.40	10.41	18.50

Updated Nov 12, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q